83 ¤1.8M FUND TO DEVELOP NOVEL MEDICAL DEVICES The COVID-19 pandemic has shone a light on the importance of the medtech industry’s ability to develop new solutions quickly in response to an urgent need. Researching and developing novel medical devices can take many years and for some companies, especially SMEs, as the associated costs, often in millions, are hugely prohibitive. The launch of MedPhab, Europe’s first pilot line for photonic-based medical devices, will leverage the experience, knowledge and capabilities of its research and business partners to drive collaboration, reduce R&D costs and accelerate commercialisation. Photonics is the science of light and is fast becoming a key enabler for the advancement of medical devices. From its use in noninvasively monitoring the lung function of babies to enabling tissue recognition to distinguish between a tumour and healthy brain tissue, light is being used to improve treatment and diagnosis for patients around world. your diet? Do you want tothe improve IPIC, the SFI Research Centre At UCD we study a new strategyfrom to improve diet quality using personalised dietary advice. research and technology The MedPhab team at Tyndall will for Photonics, led by researchers at Tyndall National Institute,
organisations with medtech
Dr David McGovern, Senior Business Development Manager at the Irish Photonics Integrated Centre, based at Tyndall National Institute, is calling on companies in the medtech sector to join MedPhab, which supports companies around the world to make novel photonic-based medical devices quicker, cheaper and more efficiently
help companies develop medtech
A healthy dietais key to and the prevention and treatment of non-communicable diseases such as solutions through technology UCC, play both technical industry leaders including Stryker diabetes disease. development support as well as commercialand role cardiovascular in MedPhab. European Operations Limited,
funding of up to ¤125k to turn their Funded by Horizon 2020, the Philips Engineering Solutions, photonic-based diagnostic and initiative launched to support We arewas looking for adults who are 18 years or older, have a poor-quality diet Radisens Diagnostics and overweight, treatment devices into companies around the world Antelope Dx to accelerateAND/OR the and have any of the following: high blood pressure high cholesterol, AND/OR industrially-relevant demonstrators to make novel photonic-based commercialisation of photoniccurrently smoke. medical devices quicker, cheaper and is available for both SMEs based diagnostic devices and and more efficiently. and MNCs. instruments. Photonics has01 been If you need more information, please contacting us at 716 6806 or a game changer for the medtech Dr David McGovern, Senior “MedPhab supports the scale metabomarkers@ucd.ie industry, driving innovation and Business Development Manager, up of Antelope Dx’s silicon advancements for both clinicians IPIC, explains, “MedPhab brings photonics functionalisation and Thank you – Teresa Grohmann and Aoife Courtney together international expertise and patients.” manufacturing processes. Having
access to the knowledge at the various partners will definitively speed up the development process and translation into actual manufacturing processes,” says Jan-Willem Hoste, COO at Antelope Dx. Companies interested in participating can visit www.medphab.eu or email david.mcgovern@tyndall.ie
DO YOU WANT TO IMPROVE YOUR DIET? At UCD we study a new strategy to improve diet quality using personalised dietary advice. A healthy diet is key to the prevention and treatment of non-communicable diseases such as diabetes and cardiovascular disease. We are looking for adults who are 18 years or older, overweight, have a poor-quality diet and have any of the following: high blood pressure AND/OR high cholesterol, AND/OR currently smoke. If you need more information, please contacting us at 01 716 6806 or metabomarkers@ucd.ie Thank you – Teresa Grohmann and Aoife Courtney
HOSPITALPROFESSIONALNEWS.IE | HPN • FEBRUARY 2022
